Lexaria Bioscience Corp.(LEXX)

$0.56—Earnings · Jul 13

Chart

Lexaria Bioscience Corp.(LEXX)

NASDAQ

$0.56—Earnings · Jul 13

Chart Studio

LEXX(LEXX)

LEXX

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.06

Jul 13, 2026 · Reports before open

Revenue Estimate

$50,000

FY2029E EPS$1.34

Analyst Sentiment

Wall St. Consensus

Buy

2 analysts·Low coverage

Score

2 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

2100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$1.50

+167.8%

Consensus

$1.50

+167.8%

Bull

$1.50

+167.8%

12-Month Target Range2 analysts

$1.50$1.50$1.50

Current $0.56Consensus

Current Price

$0.56

Upside to Consensus

$0.94

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+601.50%

EPS—

FY2028

Rev+12.97%

EPS—

FY2029

Rev+4328.14%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$200,000	$1M	$2M	$70M
Low	$180,714	$1M	$1M	$63M
High	$219,285	$2M	$2M	$77M
EBITDA Avg	$-200,000	$-1M	$-2M	$-70M
Low	$-219,285	$-2M	$-2M	$-77M
High	$-180,714	$-1M	$-1M	$-63M
EBIT Avg	$-200,000	$-1M	$-2M	$-70M
Low	$-219,285	$-2M	$-2M	$-77M
High	$-180,714	$-1M	$-1M	$-63M
Net Income Avg	$-5M	$-6M	$-5M	$24M
Low	$-5M	$-6M	$-6M	$21M
High	$-4M	$-5M	$-4M	$27M
EPS Avg	$-0.26	$-0.31	$-0.28	$1.34
Low	$-0.29	$-0.35	$-0.32	$1.17
High	$-0.23	$-0.27	$-0.24	$1.51
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027
Revenue Avg	$50,000	$22,785	$23,797	$24,854	$25,959
Low	$50,000	$22,785	$23,797	$24,854	$25,959
High	$50,000	$22,785	$23,797	$24,854	$25,959
EBITDA Avg	$-50,000	$-22,785	$-23,797	$-24,854	$-25,959
Low	$-50,000	$-22,785	$-23,797	$-24,854	$-25,959
High	$-50,000	$-22,785	$-23,797	$-24,854	$-25,959
EBIT Avg	$-50,000	$-22,785	$-23,797	$-24,854	$-25,959
Low	$-50,000	$-22,785	$-23,797	$-24,854	$-25,959
High	$-50,000	$-22,785	$-23,797	$-24,854	$-25,959
Net Income Avg	$-1M	$-7M	$-7M	$-7M	$-8M
Low	$-1M	$-7M	$-7M	$-7M	$-8M
High	$-1M	$-7M	$-7M	$-7M	$-8M
EPS Avg	$-0.06	$-0.29	$-0.28	$-0.30	$-0.31
Low	$-0.06	$-0.29	$-0.28	$-0.30	$-0.31
High	$-0.06	$-0.29	$-0.28	$-0.30	$-0.31
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Dec 26, 2025H.C. Wainwright

Lexaria Bioscience price target lowered to $1.50 from $4 at H.C. Wainwright

Target:$1.50

+167.9%from $0.56

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance